"Known Unknown": COVID and Market Volatility

"Known Unknown": covid and MARKET VOLATILITY

December 3, 2021

The emergence of Omicron, a COVID variant discovered in South Africa, has recently triggered heightened levels of market volatility. While more knowledge of this variant will surface in the coming days and weeks, at this point it may best be described as a “known unknown.” Donald Rumsfeld, the late Secretary of Defense, coined this phrase to describe events of which we are aware but lack sufficient knowledge about their potential effects. More specifically, what may the effects be of this new variant on public health, the economy, and markets?

With respect to public health effects, more research needs to be done to understand the transmissibility, severity, and distribution of this variant. However, while this research is underway, it is important to note that our current level of defense far exceeds that of just one year ago. For example, as of November 29, 2021, 59.3% of the U.S. population has been fully vaccinated, 70.8% has had at least one dose, and 12.4% has already received a booster.

As Omicron is expected to expand its reach beyond the few countries where it has been detected today, a coordinated and global effort is underway to find answers to several key questions. For example, what will be the efficacy of both current COVID vaccines and recently developed anti-viral treatments? If vaccines need to be redesigned, the outlook appears quite favorable, as the CEO of Pfizer has suggested that an Omicron-specific vaccine could be produced in about 100 days. If new vaccines are necessary, both the states and the federal government now have experience in their distribution and administration. Overall, the public health sector appears poised to respond strongly to Omicron.

With respect to Omicron’s potential effects on our economy, the strengthened state of our public health defenses is a key factor. Lockdowns, self-isolation, and travel bans were the initial and primary means of virus defense before the advent of effective vaccines, anti-viral medicines, and treatment protocols. Brutal in their execution but somewhat effective, these actions took a toll on U.S. economic activity: after the virus first emerged, gross domestic product (GDP) plummeted -32.9% in Q2 2020 alone, but then recovered for an annual GDP decline of -3.5% in 2020.

Today, it is less likely that Omicron will necessitate such Draconian measures, and more likely that unemployment levels could keep falling, schools can remain open, factories can continue to produce goods, supply chains can adjust, and the service economy (78% of GDP before COVID) can recover as well. U.S. business capital expenditures (i.e., investments in equipment, structures, and software) are expected to rise by 14% in 2021. GDP is also expected to rise by 5.5% in 2021, following a forecasted 8% rise in Q4. While Omicron may initially impact some of this forecasted growth, the public health response should avoid any repeat of the 2020 downturn.

With respect to Omicron’s potential effects on the markets, its sudden emergence proves once again the old adage that markets abhor surprises or uncertainty. Long-term, markets are generally priced and valued on fundamental financial information, but that does not prevent short-term volatility that, like on November 26, 2021, can swiftly turn into panic selling. The panic was due primarily to very limited market hours on the day after a national holiday, the absence of most institutional traders and support staff, and inadequate liquidity to absorb such massive selling during such a short period. There is no assurance that such volatility could not occur again in the future, of course.

However, when looking at fundamental financial information for the S&P 500 Index, the markets appear to have an earnings trajectory that recovers strongly from the results during COVID’s initial emergence in 2020. More specifically, as shown in the graphic below, Goldman Sachs forecasts that S&P 500 earnings will increase by 36% in 2021, 5% in 2022, 5% in 2023, and 1% in 2024. Again, the public health response to Omicron could contribute strongly to the achievement of these forecasts.

Initial uncertainty about the Omicron variant should be reduced in the coming days and weeks. In the meantime, your financial plan is designed to help you maintain progress toward achieving your financial goals. Market volatility is stressful for everyone, but The Mather Group, LLC (TMG) employs a suite of risk management tools to support your plan’s investment objectives. Your trusted advisor at TMG is ready to respond to any questions or concerns you might have, and to help ensure that your financial plan remains both timely and actionable. Please reach out to your advisor for guidance at any time.

Data Sources: Bloomberg, US Bureau of Labor Statistics, US Census Bureau, Centers for Disease Control and Prevention, FACTSET, Goldman Sachs, Johns Hopkins Bloomberg School of Public Health, Pfizer, Reuters, The Wall Street Journal.

Important Disclosure Information

The Mather Group, LLC (TMG) is registered under the Investment Advisers Act of 1940 as a Registered Investment Adviser with the Securities and Exchange Commission (SEC). Registration as an investment adviser does not imply a certain level of skill or training. For a detailed discussion of TMG and its investment advisory services and fees, see the firm's Form ADV on file with the SEC at www.adviserinfo.sec.gov. The opinions expressed, and material provided are for general information and should not be considered a solicitation for the purchase or sale of any security. The opinions and advice expressed in this communication are based on TMG’s research and professional experience and are expressed as of the publishing date of this communication. All return figures and charts shown are for illustrative purposes only. TMG makes no warranty or representation, express or implied, nor does TMG accept any liability, with respect to the information and data set forth herein. TMG specifically disclaims any duty to update any of the information and data contained in this communication. The information and data in this communication does not constitute legal, tax, accounting, investment, or other professional advice nor is it intended to provide comprehensive tax advice or financial planning with respect to every aspect of a client's financial situation. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities. Before investing, consider your investment objectives. Past performance does not guarantee future results.

An index is a portfolio of specific securities, the performance of which is often used as a benchmark in judging the relative performance of certain asset classes. Indexes are unmanaged portfolios, and investors cannot invest directly in an index. An index does not charge management fees or brokerage expenses. The Standard and Poor's (S&P) 500 is a stock market index tracking the performance of 500 large companies listed on stock exchanges in the United States.


The Mather Group

HOW SMART INVESTORS RETIRE™

Get in touch with us or find one of our office locations   Contact us

We’re passionate about growth because we know many, many households across the country could benefit from our integ… https://t.co/xHO5Xmfghn
Given the depth of research and analysis that Barron’s performs each year to compile its ranking, this recognition… https://t.co/Dn9kng6nW0